Clinical Trial Update: Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update evaluating varying doses of Lanreotide Autogel for acromegaly, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Lanreotide Autogel (lanreotide)

Snippet

Sponsor: Ipsen | Conditions: Acromegaly | Phase 2, Phase 3 | Status: COMPLETED